Mitsudomi T, Lam S, Shirakusa T, Gazdar A F
NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, MD.
Chest. 1993 Aug;104(2):362-5. doi: 10.1378/chest.104.2.362.
We demonstrated the feasibility of detection of p53 gene mutations in bronchial biopsy samples from patients with lung cancer. Following DNA extraction from two to three pieces of bronchial tissue obtained by fiberoptic bronchoscopy, p53 gene mutations were screened using polymerase chain reaction/single-strand conformation polymorphism technique. We examined four bronchial biopsy specimens from patients with squamous cell carcinoma of the lung and detected one point mutation at codon 130 (C to G, Leu to Val). This technique will be very useful for studies on early detection of lung cancers or for an analysis of a suspected premalignant lesion. Furthermore, this technique enables us to know the status of oncogene or tumor suppressor gene at the time of diagnosis, which may be very useful for a treatment of patients with cancer in the not too distant future.
我们证明了在肺癌患者的支气管活检样本中检测p53基因突变的可行性。从通过纤维支气管镜获取的两到三块支气管组织中提取DNA后,使用聚合酶链反应/单链构象多态性技术筛选p53基因突变。我们检查了4例肺鳞状细胞癌患者的支气管活检标本,在第130密码子处检测到1个点突变(C到G,亮氨酸到缬氨酸)。该技术对于肺癌早期检测研究或疑似癌前病变分析将非常有用。此外,该技术使我们能够在诊断时了解癌基因或肿瘤抑制基因的状态,这在不久的将来对癌症患者的治疗可能非常有用。